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2Interpretive summary: LE-CLA and Reproduction. Hutchinson25
Reducing milk energy output in early lactation could be a viable strategy to improve energy26
status and subsequent fertility in dairy cows, thereby reducing the economic impact of poor27
reproductive performance. Cows were fed either a conjugated linoleic acid supplement or a28
control supplement daily for 60 d after calving. Milk production, milk progesterone29
concentrations, and reproductive performance were monitored. Milk fat production was30
reduced but milk yield was increased, resulting in no net energy saving effect. Reproductive31
performance was unaffected by supplementing lactating dairy cows with conjugated linoleic32
acid.33
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3ABSTRACT50
The objective was to determine the effects of a protected (lipid-encapsulated) conjugated51
linoleic acid (LE-CLA) supplement on milk production, estrous cycle characteristics, and52
reproductive performance in lactating dairy cows on a pasture-based diet. Spring calving53
dairy cows (n = 409) on a single pasture-based commercial dairy farm were used in a54
completely randomized block design. Cows were assigned to 1 of 2 dietary supplements (LE-55
CLA (Lutrell®, BASF, Germany; n = 203) or no supplement (Control, n = 206)). The LE-56
CLA cows received 51 g/d of a lipid supplement containing 5 g of both trans-10, cis-12 and57
cis-9, trans-11 CLA from 0 to 60 d in milk. Milk samples were collected 3 times weekly, and58
each sample was analyzed for progesterone to determine interval to first ovulation and59
estrous cycle characteristics. Milk yield and concentrations of fat, protein, and lactose were60
measured fortnightly. Cows were inseminated following visual observation of estrus. The61
breeding season commenced on April 8, 2009 and continued for 16 wk. Trans-rectal62
ultrasonography was carried out at 30 to 36 d and 60 to 66 d post AI to diagnose pregnancy.63
The LE-CLA treatment resulted in a reduction in milk fat concentration (36.9 g/kg ± 0.0664
g/kg vs. 30.7 g/kg ± 0.06 g/kg Control and LE-CLA, respectively) and yield (0.91 kg/d ± 0.0265
kg/d vs. 0.84 kg/d ± 0.02 kg/d Control and LE-CLA, respectively); however, milk yield was66
increased by LE-CLA supplementation (24.7 kg/d ± 0.7 kg/d vs. 27.2 kg/d ± 0.7 kg/d,67
Control and LE-CLA, respectively), resulting in no overall difference in milk energy output.68
There was no effect of LE-CLA on any estrous cycle characteristics or measures of69
reproductive performance. These results suggest that in pasture-based systems of dairy70
production, where energy intake limits milk production, energy spared by CLA-induced milk71
fat depression is partitioned towards increasing milk yield rather than towards body reserves.72
Key words: conjugated linoleic acid, reproduction, milk fat, energy balance.73
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4INTRODUCTION75
The early postpartum period in dairy cattle is associated with negative energy balance76
(NEB) and mobilization of body reserves, as the energy requirements for maintenance and77
milk production exceed energy ingested (Bauman and Currie, 1980). Both the duration and78
severity of this period of NEB have detrimental effects on follicle development, postpartum79
resumption of ovarian cyclicity, and subsequent oocyte and embryo quality, resulting in80
reduced pregnancy rates (Beam and Butler, 1999; Diskin et al., 2003; Leroy et al., 2008).81
Attempts to alleviate NEB have largely focused on increasing the energy density of82
the diet. Feeding supplemental fat generally results in an increase in nutrients partitioned83
towards milk production (Santos et al., 2008), or else DMI is suppressed so that total energy84
intake is unaffected (Staples et al., 1998).85
Improved reproductive performance was reported in some studies where lactating86
dairy cows were supplemented with polyunsaturated fatty acids. Although results have been87
inconsistent (Santos et al., 2008), it would appear that reproductive performance may be88
improved by the specific effects of individual fatty acids, independent of energy status.89
Conjugated linoleic acids (CLA) are geometric and positional isomers of linoleic90
acid, and are normally found in the rumen as intermediates in the biohydrogenation of91
linoleic to stearic acid. Trans-10, cis-12 CLA was identified as a potent inhibitor of milk fat92
synthesis (Baumgard et al., 2002), with a dose-dependent response of up to 50% reduction in93
milk fat synthesis (de Veth et al., 2004). Milk volume and milk protein concentration were94
not reduced by CLA supplementation, and milk fat concentration quickly returned to control95
levels on termination of CLA supplementation (Castaneda-Gutierrez et al., 2007). Fat is the96
most energetically expensive component of milk, representing up to 35% of net energy intake97
in early lactation (Bauman and Currie, 1980). Feeding supplemental CLA may be a means of98
reducing milk energy output and ameliorating NEB postpartum, with subsequent99
5improvements in reproductive performance. Some studies reported no improvement in energy100
status, with energy spared being partitioned towards increased milk volume (Bernal-Santos et101
al., 2003), whereas other reports indicated reductions in milk energy output with CLA102
supplementation (Odens et al., 2007; Hutchinson et al., 2011). A recent meta-analysis of 5103
controlled studies in which early-lactation dairy cows had been supplemented with CLA104
indicated that CLA supplementation reduced interval to first ovulation and time to105
conception, and increased the probability of cows becoming pregnant (de Veth et al., 2009).106
The studies included in the meta-analysis utilized a small number of cows (total n = 212), and107
determining the effects of CLA on reproductive performance was not a primary objective in108
any of the 5 studies included in the meta-analysis. To date, there has been no herd scale109
evaluation of the effect of lipid-encapsulated CLA on reproductive performance in lactating110
dairy cattle. The aim of the present study was to examine the effects of CLA supplementation111
on milk production and reproductive performance of lactating dairy cows in a pasture-based112
system of production under commercial conditions.113
MATERIALS AND METHODS114
Animals, Treatments and Sampling115
A total of 409 primiparous and multiparous spring-calving Holstein-Friesian dairy116
cows on a single pasture-based commercial dairy farm in County Cork, Ireland (52°05'N;117
8°16'W) were blocked on the basis of parity (1, 2, and > 2) and calving date, and randomly118
assigned to receive 1 of 2 dietary treatments from parturition until 60 DIM: protected (lipid-119
encapsulated) LE-CLA (n = 203; Lutrell®, BASF, Ludwigshafen, Germany) or no120
supplement (Control, n = 206). The mean calving date was 23rd February 2009 (SD = 29 d;121
range = 4 January 2009 to 26 April 2009). Prior to parturition, all cows were managed in the122
same manner, housed indoors, and fed a grass silage diet. Following parturition, the cows123
were managed as a single herd and milked twice daily at 0700 and 1600 h in a 60-unit rotary124
6parlor with automatic cow identification, automatic concentrate feeding, and electronic milk125
meters (Dairymaster, Causeway, Kerry, Ireland). Every cow was offered the same basal diet126
of grazed grass and a concentrate ration fed in the parlor at milking times. In late winter and127
early spring, when grass growth was limited by weather conditions, they were fed a forage128
diet based on a 50:50 mix of grass silage and corn silage supplemented with 2 kg/cow per day129
of soybean meal. The parlor concentrate supplement was fed at a rate of 6 kg/cow per day in130
late winter, and was gradually reduced to 1 kg/cow per day as grass growth increased. The131
chemical composition of the feeds offered (Partial Mix Ration, silage mix, grazed grass, and132
parlor concentrate supplement) is shown in Table 1. The LE-CLA cows were individually fed133
an additional 51 g/d of lipid supplement from parturition until 60 DIM. The LE-CLA134
supplement contained a 50:50 mix of cis-9, trans-11 CLA and trans-10, cis-12 CLA,135
resulting in a daily intake of 5 g/d of each isomer. The LE-CLA supplement was136
automatically dispensed to individual cows in granular form using a PowerDos® feeding137
system (Hanskamp AgroTech BV, Zelhem, The Netherlands) simultaneous with the138
concentrate allocation. The PowerDos® system delivered the supplement from a hopper via a139
pneumatic stainless steel dosage mechanism. As this mechanism was able to deliver a140
maximum of 17 g of LE-CLA in a single dose, the feeding system was programmed to feed a141
double dose (34 g) at the morning milking and a single dose (17 g) at the evening milking.142
The feeding system was tested a number of times before the initiation of the study and at143
fortnightly intervals to ensure that the correct amount of LE-CLA was being provided to the144
cows. Milk yield was recorded daily at morning and evening milkings using electronic milk145
meters (Dairymaster). Milk composition (fat, protein, and lactose), was determined on a146
fortnightly basis from successive morning and evening milk samples by automated infra-red147
absorption analysis using a Milkoscan 605 (Foss Electric, Hillerød, Denmark).148
7The following equation was used to determine the milk energy output (O' Mara,149
1997), using unité fourragère lait (UFL) as the unit of net energy, which is equivalent to 1 kg150
of standard air-dried barley.151
Energy requirement for milk (UFL/kg of milk) = 0.0054 FC + 0.0031 PC + 0.0028152
LC - 0.015;153
where FC = fat concentration (%), PC = protein concentration (%), and LC = lactose154
concentration (%).155
A total of 20 cows (9 Control, 11 CLA), were removed from the experiment due to156
illnesses and metabolic problems unrelated to dietary treatment.157
Milk progesterone sampling and analysis158
Milk samples from all cows enrolled in the study were collected at the morning159
milking 3 times weekly (Monday, Wednesday, and Friday); a preservative was added to each160
sample (Lactab Mark III, Thomson and Capper Ltd., Cheshire, UK) and the samples were161
stored at 4 °C until analysis. Milk progesterone (P4) concentrations were measured in162
representative samples from every cow on each sampling date using a competitive ELISA163
test (Ridgeway Science, Gloucester, UK), based on published methods (Sauer et al., 1986).164
The inter- and intra-assay coefficients of variation were 14.5 % and 9.1 %, respectively, and165
the sensitivity of the assay was 0.5 ng/mL (Sauer et al., 1986).166
Interval to first ovulation167
A period of luteal activity was defined as the occurrence of 2 or more consecutive168
milk P4 concentrations ≥ 3 ng/mL (Darwash et al., 1997). The interval to first ovulation169
(IOV1) was defined as the first occurrence of luteal activity postpartum, or the first day on170
which milk P4 concentrations ≥ 3 ng/mL were observed, and meeting the above criteria.171
Abnormal estrous activity172
8Abnormal estrous activity was identified based on previously published criteria173
(Royal et al., 2000). Prolonged anovulation postpartum, delayed ovulation type I (DOV I),174
was defined as milk P4 concentrations < 3 ng/mL for ≥ 45 DIM. Prolonged inter-luteal175
interval, delayed ovulation type II (DOV II), was defined as milk P4 concentrations < 3176
ng/mL for ≥ 12 d after the first occurrence of luteal activity postpartum. Delayed luteolysis177
during the first estrous cycle postpartum, persistent corpus luteum type I (PCL I), was178
defined as milk P4 concentrations ≥ 3 ng/mL for ≥ 19 d during the first postpartum estrous179
cycle. Delayed luteolysis during subsequent estrous cycles before AI, persistent corpus180
luteum type II (PCL II), was defined as milk P4 concentrations ≥ 3 ng/mL for ≥ 19 d during181
subsequent postpartum estrous cycles.182
Characteristics of the estrous cycle outlined above were determined before the first183
postpartum AI. In total, results were available from 306, 371, 223, 250, and 146 cows for184
IOV1, DOVI, DOVII, PCLI, and PCLII, respectively.185
Fatty acid analysis186
Milk samples were collected from 15 cows on each treatment at 30 and 60 DIM, and187
the samples were analyzed for milk fatty acid composition. The samples were analyzed by188
gas liquid chromatography according to the method developed by (Collomb et al., 2000)189
following extraction and methylation according to ISO standards 14156:2001 (ISO, 2001)190
and 15884:2002 (ISO, 2002). Samples of the feed offered were collected at these time points191
and fatty acid content was determined by gas liquid chromatography as described by Childs192
et al (2008) following lipid extraction using a chloroform, methanol and water mixture (Folch193
et al., 1957), and methylation using NaOCH3, methanol, and BF3 (Park and Goins, 1994). The194
fatty acid composition of the feeds offered is shown in Table 2.195
Breeding and reproductive performance196
9Breeding commenced on April 8, 2009, and continued for 16 wk. Artificial197
insemination was carried out by a single experienced technician, and took place after morning198
and evening milkings. Cows were AI 12 h after first showing signs of estrus. Tail paint and199
MooMonitor activity collars (Dairymaster) were used to aid heat detection. Body condition200
score was assessed (Edmonson et al., 1989) on 4 fixed calendar dates during the breeding201
season. The BCS assessment commenced on the 5 April 2009 and took place on fixed202
calendar dates at intervals of approximately 4 wk thereafter. As a result, some of the LE-CLA203
cows were still receiving the LE-CLA supplement for the first 2 BCS assessment dates,204
whereas others had finished the LE-CLA supplementation period before the first BCS205
assessment date of April 5, 2009. Trans-rectal ultrasonography was carried out at 30 to 36 d206
and 60 to 66 d post AI using a 5.0-MHz transrectal transducer (Aloka SSD-500; Aloka Ltd.,207
Tokyo, Japan) to diagnose pregnancy. Visualization of a fluid-filled horn and a viable208
embryo were used for positive identification of pregnancy. Three-week submission rate was209
defined as the proportion of cows inseminated within the first 3 wk of the breeding season.210
Six-week in calf rate was defined as the proportion of cows pregnant within the first 6 wk of211
the breeding season. Overall pregnancy rate was defined as the proportion of cows pregnant212
at the final herd scan on the 2 December 2009. Cows that underwent embryo loss were213
defined as cows that were diagnosed as pregnant at 30 to 36 d post-AI, but were then214
diagnosed as non-pregnant at 60 to 66 d post-AI.215
Statistical analysis216
All statistical analysis was carried out using SAS (SAS System Inc., Cary, NC). Milk217
production, milk composition, and BCS data were analyzed using the MIXED procedure of218
SAS with repeated measures, using the Satterthwaite adjustment to calculate denominator219
degrees of freedom. The appropriate covariance structure for each repeated measures analysis220
was identified based on Akaike’s Information Criterion model fit statistic. A first order221
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autoregressive covariance structure was selected. Treatment, treatment week, and their222
interaction were included as fixed effects, and block was included as a random effect. Parity223
and calving day of year were included as adjustment variables in all repeated measures224
models; if non-significant, these variables were removed and the models were re-run. Data225
for IOV1, the interval from calving to first AI, and interval from calving to conception were226
evaluated by the LIFETEST procedure of SAS using Kaplan-Meier analysis to investigate the227
effect of treatment on the number of days from calving to commencement of luteal activity,228
first AI, and conception. The IOV1 was right-censored at 60 d, calving to service interval was229
right-censored at the last date of AI use (15 June), and calving to conception interval was230
right-censored at the last date of the breeding period (25 September). All of the binary231
reproductive performance variables were analyzed using the FREQ procedure of SAS with232
the Chi-squared test.233
RESULTS234
Milk production and BCS235
The milk production results are summarized in Table 3 and Figure 1. Milk fat236
concentration was reduced by LE-CLA treatment (P < 0.001), but the treatment by time237
interaction effect was not significant. During the supplementation period, milk fat yield was238
reduced (P = 0.03) by up to 8%, milk yield was increased (P = 0.003), and milk protein239
concentration was reduced (P < 0.001). Milk solids yield (fat plus protein) was not affected.240
Milk fat concentration and yield in LE-CLA supplemented cows began to return towards241
levels similar to control cows after the end of the supplementation period (Figure 1).242
Supplementing cows with LE-CLA tended to increase BCS (P = 0.09, Figure 2).243
Estrous cycle characteristics244
Estrous cycle characteristics and IOV1 results are presented in Table 4. There was no245
effect of LE-CLA supplementation on IOV1 (40.2 ± 1.05 d vs. 40.3 ± 1.19 d, Control and246
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LE-CLA respectively, Log Rank Probability of Chi-Square test = 0.87). The proportion of247
cows that continued to be anestrous at 60 DIM was 0.23 and 0.25 for Control and CLA,248
respectively. Incidence of DOV I (35.1% vs. 36.1%) and DOV II (16.7% vs. 14.6%) were not249
affected by LE-CLA supplementation (both P > 0.6). The LE-CLA supplementation had no250
effect on the incidence of PCL I (8.9% vs. 10.3%) or PCL II (8.9% vs. 7.5%, both P > 0.6).251
Reproductive performance252
Reproductive performance data are summarized in Table 5. There was no effect of253
LE-CLA supplementation on the interval from calving to first insemination (71.8 ± 1.84 d vs.254
70.9 ± 1.79 d, Control and LE-CLA, respectively, Log Rank Probability of Chi-Square test =255
0.5), or the interval from calving to conception (123.7 ± 4.68 d vs. 130.4 ± 4.66 d, Control256
and LE-CLA, respectively, Log Rank Probability of Chi-Square test = 0.2). There was no257
effect of LE-CLA supplementation on conception rate to first (35.1 vs. 37.0; Control and LE-258
CLA, respectively) or second service (38.5% vs. 29.9%, both P > 0.2). There was also no259
effect of CLA supplementation on 3 week submission rate (54.8% vs. 58.0%, P = 0.5),260
embryo loss to first service (15.2% vs. 17.9%, P = 0.7), 6 week in-calf rate (43.6% vs. 37.0%,261
P = 0.2), or overall pregnancy rate (80.7% vs. 76.0%, P = 0.3).262
Milk fatty acid analysis263
CLA supplementation reduced (all P < 0.01) the proportion of most short and medium264
chain fatty acids in milk fat compared to control animals (Table 6), with the exception of265
C4:0, C14:0 and C15:0 which were not affected (all P > 0.3). The proportion of C16:0 in266
milk fat was not affected by CLA supplementation (P > 0.1). The LE-CLA supplementation267
tended to increase (P = 0.07) the proportion of C18:0 in milk fat, and increased the268
proportion of cis-9 C18:1 and cis-9, trans-11 CLA in milk fat (both P < 0.04). There was no269
effect of CLA supplementation on any other long chain fatty acids measured (all P > 0.08).270
Overall, this resulted in a decrease in the proportion of de novo synthesized (< C16:0) fatty271
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acids (P = 0.03), and an increase in the proportion of preformed (> C17:0) fatty acids in the272
milk fat of cows fed the LE-CLA supplement.273
DISCUSSION274
The feeding and management systems utilized in this study enabled accurate and275
reliable supplementation with LE-CLA to individual cows on a large herd scale, the first time276
this has been achieved. We have demonstrated that LE-CLA supplementation during the first277
60 DIM can be used as a management tool to temporarily reduce milk fat synthesis in278
pasture-based dairy cows. Despite observing a trend towards an improvement in BCS in cows279
supplemented with LE-CLA, the lack of an effect of LE-CLA on milk energy output suggests280
that most energy spared by reducing milk fat synthesis was partitioned towards increasing281
milk production. There was no effect of LE-CLA supplementation on any measure of282
reproductive performance or estrous cycle characteristics.283
Fat is an economically important component of milk to dairy farmers. Extreme milk284
fat depression (MFD) may be undesirable, especially in regions where milk is primarily used285
for manufacturing purposes. Results from a previous study (Hutchinson et al., 2011) provided286
the justification for the level and duration of LE-CLA supplementation used in the present287
study to induce sufficient MFD to potentially improve energy status, but not markedly288
decrease income from milk.289
The CLA dose fed in the present study (5 g/d trans-10, cis-12 CLA) is similar to that290
fed by Hutchinson et al. (2011), although the supplement was fed in pelleted form, whereas in291
the current study the granular supplement was fed directly to the cows, avoiding any potential292
degradation of the supplement during the pelleting process. In the current study a reduction in293
milk fat concentration in LE-CLA cows occurred within a week after the initiation of294
treatment. There is no evidence of any adaptation to the treatment, as the data in Figure 1295
show that maximal milk fat depression occurred at wk 8 postpartum, at the end of the296
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treatment period. We observed a maximum depression in milk fat concentration of 18.8%,297
greater than the 15.7% observed by (Hutchinson et al., 2011), who fed the same supplement298
but at a greater dose of 6.9 g/d of trans-10, cis-12 LE-CLA. The greater reduction in milk fat299
concentration in the present study may suggest an improved efficacy of the supplement, most300
likely attributable to avoiding any potential degradation during the pelleting process, as noted301
by Hutchinson et al., (2011).302
The increase in milk yield in the current study supports the work of Bernal-Santos et303
al. (2003) and Mackle et al. (2003), but differs from the findings of Hutchinson et al. (2011),304
and Castaneda-Gutierrez et al. (2005). Moore et al. (2004) hypothesized that during early305
lactation the extra energy afforded by a reduction in milk fat synthesis may be partitioned306
towards protein synthesis and milk production. We observed an increase in milk production,307
though there was a small, but statistically significant, reduction in milk protein concentration.308
Because of the increased milk yield, however, milk protein yield was not affected. There was309
also a reduction in milk lactose concentration with LE-CLA supplementation, but milk310
lactose yield was increased due to greater milk volume. To our knowledge, the current study311
is the first to report a reduction in milk lactose concentration with CLA supplementation.312
Overall, although milk constituent concentrations were reduced, the increase in milk313
synthesis negated these effects and resulted in no differences in milk solids yields.314
In the current study LE-CLA supplementation caused a reduction in the secretion of315
all fatty acids, but those of de novo origin were reduced to a greater extent. The LE-CLA316
reduced the proportion of de novo fatty acids and increased the proportion of preformed fatty317
acids in milk fat, results that support previous reports (Kay et al., 2007; Moore et al., 2004;318
Perfield et al., 2002). Trans-10, cis-12 CLA reduces milk fat synthesis through coordinated319
decreases in expression of genes encoding key enzymes involved in the uptake and transport320
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of preformed fatty acids, in addition to enzymes involved in the desaturation of fatty acids,321
formation of triglycerides, and de novo fatty acid synthesis (Baumgard et al., 2002).322
Although the milk fat depressing effects of CLA are generally accepted, the323
subsequent effect on energy status is more equivocal. Some studies reported improvements in324
energy status with CLA supplementation (Hutchinson et al., 2011; Odens et al., 2007);325
however, absence of an effect of CLA on energy status was also reported in a number of326
studies (Bernal-Santos et al., 2003; Castaneda-Gutierrez et al., 2005). In studies where CLA327
did not improve energy status, it was generally hypothesized that any energy saved from the328
reduction in milk fat synthesis was partitioned towards greater milk production, such that329
milk energy output remained unchanged (Bernal-Santos et al., 2003). The present study330
differs from previous reports in that milk energy output was unaffected by LE-CLA331
supplementation, but a trend towards improved BCS in LE-CLA treated cows was also332
observed. Although we detected a statistical trend towards improved BCS in LE-CLA333
supplemented cows, the degree to which BCS was improved is marginal (less than 0.05 BCS334
units), and the ability to detect an improvement in BCS was most likely attributed to the large335
number of cows on the study. Due to the on-farm nature of the current study, it was not336
possible to measure DMI. In previous studies where DMI has been measured, CLA had no337
effect on DMI in cows consuming a TMR (Bernal-Santos et al., 2003; Moore et al., 2004) or338
pasture (Kay et al., 2007; Kay et al., 2006) diet.339
Mackle et al. (2003) suggested that energy spared from a reduction in milk fat340
synthesis is likely to have a greater positive impact on milk production in pasture-fed cows341
than cows fed a TMR diet that could more closely meet energy requirements. The current342
study, along with data from Kay et al. (2006), Mackle et al. (2003), and Medeiros et al.343
(2010) support this hypothesis. The work of Kay et al. (2007) is the only study in cows344
receiving a pasture diet in which CLA-induced MFD resulted in decreased milk energy345
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output, but was not accompanied by an increase in milk yield. In that study much greater346
levels of MFD were achieved (> 40%) due to abomasal infusion of the CLA, which avoided347
rumen biohydrogenation of the supplement. Positive milk yield responses were not observed348
at more severe (> 35%) levels of MFD (Kay et al., 2006). It is reasonable to conclude that in349
pasture-based systems of dairy production, where milk production is limited by energy350
intake, the extra energy spared by CLA-induced MFD is partitioned towards milk production351
rather than body reserves. It seems likely that overall energy status is only improved in352
situations where the cow is already producing at full potential.353
There was no effect of LE-CLA on any of the reproduction variables or estrous cycle354
characteristics measured. No previous work in which dairy cows were supplemented with355
CLA investigated the effects on estrous cycle characteristics, although there is a body of356
work from which we can draw general comparisons. The overall incidence of both DOV I357
(35.1%) and DOV II (15.7%) in the current study is greater than observed by Opsomer et al.358
(1998) (20.5% and 3%) and Royal et al. (2000) (12.9% and 10.6%). The high incidence of359
delayed ovulation observed in the present study is indicative of a widespread fertility problem360
in the herd, as cows with extended postpartum anestrus intervals had lower submission,361
conception, and pregnancy rates than cycling animals (McDougall et al., 2001). This is362
reflected in the sub-optimal fertility performance of the herd, with conception rates to first363
service in the current study (35.1 to 37.0%) less than reported in pasture-based systems364
(Horan et al., 2004: 47 to 56%; Buckley et al., 2003: 49%). Similarly, the embryo loss rates365
of 15.2 to 17.9% were greater than those reported by Silke et al. (2002) (6.1 to 7.2%) and366
Horan et al. (2004) (7.5%), from comparable studies in Irish pasture-based dairy herds.367
Figures of 54 to 58% for 3-wk submission rate and 37 to 44% for 6-wk in-calf rate in the368
current study are less than the target rates for seasonal-calving pasture based systems of >369
80% for 3-wk submission rate and > 68% for 6-wk in-calf rate (McDougall, 2006).370
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There are a wide range of latent factors that act to negatively impact reproductive371
performance in dairy cows on commercial dairy farms. These include infectious disease372
status, macro and trace mineral nutrition status, and a variety of other stressors. It is possible373
that LE-CLA supplementation has no beneficial effect on reproductive performance, as the374
results of this study suggest. It is also possible, however, that one or more factors may have375
been present on the farm that acted to antagonize cow fertility, and this overrode any376
potential beneficial effect of LE-CLA.377
CONCLUSIONS378
Supplementation with LE-CLA induced milk fat depression in early lactation, pasture379
fed dairy cows. Due to increased milk yield in LE-CLA supplemented cows, there was no380
effect on milk energy output. There was no effect of LE-CLA supplementation on any estrous381
cycle characteristic or measure of reproductive performance. In grass-based systems of dairy382
production, where milk production is limited by energy intake, any energy spared by a383
reduction in milk fat synthesis is partitioned towards increased milk production rather than384
improving the energy status and subsequent reproductive performance of the cow.385
386
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Table 1. Chemical composition of the feeds offered to dairy cows on pasture.502
Nutrient Composition (g/kg DM) Grass PMR1 Concentrate
OM digestibility 818.3 706.0 -
CP 256.4 120.1 249.2
NDF 487.6 480.0 -
ADF 253.8 274.7 -
Crude fiber - - 109.2
Oil - - 38.4
Ash 90.6 64.8 80.7
1Partial Mix Ration503
504
505
506
507
508
509
510
511
512
513
514
515
Table 2. Fatty acid composition (g/100 g of total fatty acids) of the feeds offered to dairy516
cows on pasture517
% of total fatty acids
23
Fatty acid Grass PMR1 Concentrate LE-CLA2
12:0 1.87 1.16 0.57 0.34
12:1 1.71 1.52 0.03 --
13:0 1.09 1.08 -- 0.34
13:1 cis-12 1.28 0.68 -- --
14:0 1.54 3.88 0.93 1.11
trans 14:1 -- 0.12 -- --
15:0 -- -- 0.42 0.13
15:1 trans-10 2.33 1.79 0.16 --
15:1 cis-10 3.86 2.69 -- --
16:0 20.32 26.68 32.29 13.96
cis 16:1 2.31 1.16 0.63 0.07
trans 16:1 -- 1.06 -- --
17:0 -- 0.23 0.17 0.21
17:1 cis-10 -- 0.29 -- 0.04
18:0 1.03 2.24 1.70 33.28
18:1 cis-9 1.62 5.51 13.23 12.07
18:1 trans-9 -- 0.52 1.50 0.23
18:2 cis-9, cis-12 5.58 15.15 36.32 1.01
18:2 cis-9, trans-11 CLA3 -- -- -- 12.42
18:2 trans-10, cis-12 CLA -- -- -- 13.72
All trans 18:2 0.57 0.80 0.17 2.60
18:3 cis-6, cis-9, cis-12 -- 0.11 -- --
18:3 cis-9, cis-12, cis-15 41.76 18.05 3.20 0.02
20:0 0.07 0.44 0.44 1.10
24
20:1 cis-11 -- -- 0.45 0.09
20:2 cis-11, cis-14 -- -- -- 0.03
22:0 1.10 2.01 0.74 2.69
22:1 1.85 0.69 0.16 --
22:4 1.41 2.74 1.44 1.23
Total 91.36 90.60 94.53 96.69
1Partial Mix Ration518
2Lipid encapsulated conjugated linoleic acid519
3Conjugated linoleic acid520
521
522
523
524
525
526
527
25
Table 3. Milk production and composition of cows on lipid-encapsulated conjugated linoleic528
acid (LE-CLA) and control treatments529
P-value
Control LE-CLA1 SEM Trt Trt x Time
Milk yield (kg/d) 24.7 27.2 0.7 0.003 0.7
Milk fat (g/kg) 36.9 30.7 0.6 <0.001 0.2
Milk fat yield (kg/d) 0.91 0.84 0.02 0.031 0.7
Milk protein (g/kg) 32.8 31.2 0.3 <0.001 0.9
Milk protein yield (kg/d) 0.81 0.85 0.02 0.11 0.9
Milk lactose (g/kg) 47.5 46.4 0.3 0.028 0.9
Milk lactose yield (kg/d) 1.18 1.28 0.03 0.012 0.9
Milk solids yield (kg/d)2 1.72 1.69 0.05 0.6 0.9
FCM yield (kg/d) 3 25.39 25.33 0.66 0.9 1.0
Milk energy output (UFL4/d)5 10.32 10.32 0.27 1.0 1.0
SCS6 101.6 (73.2 - 141.1) 96.2 (69.3 -133.8) - 0.8 0.3
1Lipid encapsulated conjugated linoleic acid530
2Milk solids yield = milk fat yield (kg/d) + milk protein yield (kg/d)531
33.5% FCM yield = 0.4318 * milk yield (kg/d) + 16.23 * milk fat yield (kg/d)532
4UFL = unité fourragère lait; unit of net energy, equivalent to 1 kg of standard air-dried533
barley534
5Milk energy output = 0.054 * fat concentration (%) + 0.031 * protein concentration (%) +535
0.028 * lactose concentration (%) - 0.015.536
26
6SCS is calculated by taking the natural logarithm of SCC values. Values are back-537
transformed least square means followed by 95% confidence limits in parenthesis.538
539
540
541
542
543
544
545
546
547
548
549
550
551
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Table 4. Estrous cycle characteristics of cows on lipid-encapsulated conjugated linoleic acid552
(LE-CLA) and control treatments553
Control LE-CLA1 P-value
Interval to first ovulation (d)2 40.2 (± 1.05) 40.3 (± 1.19) 0.9
Incidence of DOV I (%)3 35.1 (67/191) 36.1 (65/180) 0.8
Incidence of DOV II (%)4 16.7 (20/120) 14.6 (15/103) 0.7
Incidence of PCL I (%)5 8.9 (11/124) 10.3 (13/126) 0.7
Incidence of PCL II (%)6 8.9 (7/79) 7.5 (5/67) 0.8
1 Lipid encapsulated conjugated linoleic acid554
2Interval to first ovulation data are mean values followed by the standard error of the mean in parenthesis.555
3DOV I (Delayed ovulation type I) = milk P4 < 3 ng/mL for ≥ 45 days post partum556
4DOV II (Delayed ovulation type II) = milk P4 < 3 ng/mL for ≥ 12 days after the first occurrence of luteal557
activity558
5PCL I (Persistent corpus luteum type I) = milk P4 ≥ 3 ng/mL for ≥ 19 days during the first post-partum oestrus559
cycle560
6PCL II (Persistent corpus luteum type II) = milk P4 ≥ 3 ng/mL for ≥ 19 days during subsequent post-partum561
oestrus cycles562
563
564
565
566
567
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Table 5. Reproductive performance of cows on lipid-encapsulated conjugated linoleic acid568
(LE-CLA) and control treatments569
Control LE-CLA1 P-value
Calving to first service interval (d)2 71.8 (± 1.79) 70.9 (± 1.84) 0.5
Calving to conception interval (d)3 123.7 (± 4.68) 130.4 (± 4.66) 0.2
3 week submission rate (%)4 54.8 (103/188) 58.0 (105/181) 0.5
Conception rate to first service (%) 35.1 (66/188) 37.0 (67/181) 0.7
Conception rate to second service (%) 38.5 (37/96) 29.9 (26/87) 0.2
Embryo loss to first service (%)5 15.2 (10/66) 17.9 (12/67) 0.7
6 week in-calf rate (%)6 43.6 (82/188) 37.0 (67/181) 0.2
Overall pregnancy rate (%)7 80.7 (159/197) 76.0 (146/192) 0.3
1Lipid encapsulated conjugated linoleic acid570
2Calving to first service interval data are mean values followed by the standard error of the571
mean in parenthesis.572
3Calving to conception interval data are mean values followed by the standard error of the573
mean in parenthesis574
43 week submission rate = proportion of cows inseminated in the first 3 weeks of the575
breeding season.576
5Cows that underwent embryo loss were defined as cows that were scanned as pregnant at the577
30 to 36 d post insemination scan, but were then scanned as non-pregnant at the 60 to 66 d578
post insemination scan.579
66 week in-calf rate = proportion of cows pregnant in the first 6 weeks of the breeding season580
7Overall pregnancy rate = proportion of cows pregnant at the final herd scan581
29
Table 6. Milk fatty acid composition (g/100 g total fatty acids) of cows on lipid-encapsulated582
conjugated linoleic acid (LE-CLA) and control treatments583
Control LE-CLA1 SEM P value
4:0 2.71 2.67 0.073 0.74
6:0 1.86 1.67 0.050 0.004
8:0 1.22 1.04 0.043 0.001
10:0 2.83 2.41 0.131 0.002
10:1 0.27 0.22 0.020 0.008
12:0 3.38 2.97 0.169 0.008
12:1 cis and 13:0 0.31 0.27 0.014 0.009
14:0 10.97 10.69 0.398 0.43
15:0 1.60 1.52 0.038 0.129
16:0 25.00 24.03 0.728 0.132
16:1 cis-9 1.79 1.78 0.097 0.822
17:0 1.15 1.11 0.022 0.114
18:0 10.98 11.74 0.632 0.07
18:1 cis-9 21.58 23.18 0.739 0.032
Other 18:1 7.78 7.71 0.257 0.857
18:2 cis-9, cis-12 1.28 1.35 0.079 0.312
Other 18:2 1.47 1.56 0.073 0.409
18:2 cis-9, trans-11 CLA 1.59 1.92 0.104 0.023
18:3 cis-9, cis-12, cis-15 0.67 0.75 0.050 0.116
20:0 0.10 0.11 0.007 0.085
20:5 EPA 0.09 0.09 0.005 0.947
22:0 0.17 0.10 0.053 0.363
30
22:5 DPA 0.11 0.11 0.008 0.452
Fatty acid origin
De novo2 25.17 23.48 0.820 0.03
16:0 and 16:1 26.81 25.81 0.796 0.145
Preformed3 47.13 49.88 1.514 0.026
1Lipid encapsulated conjugated linoleic acid584
2Milk fatty acids synthesized in the mammary gland of chain length C4 - C15585
3Milk fatty acids derived from the uptake of circulating fatty acids, of chain length greater586
than C16587
588
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Figure 1. Temporal changes in milk yield, milk fat concentration, and milk fat yield during607
the treatment and post-treatment periods. The treatment period lasted from parturition to 60608
DIM, and cows were fed either no supplement (CTL), or 51 g/d of lipid-encapsulated609
conjugated linoleic acid (LE-CLA). The LE-CLA supplement provided 5 g/d of both cis-9,610
trans-11 CLA and trans-10, cis-12 CLA. All values are LSM.611
612
Figure 2. Effect of treatment on BCS. Body condition score was assessed on fixed calendar613
dates, just prior to the start of mating, followed by measurements approximately 6 wk apart.614
The treatment period lasted from parturition to 60 DIM, and cows were fed either no615
supplement (CTL), or 51 g/d of lipid-encapsulated conjugated linoleic acid (LE-CLA). The616
LE-CLA supplement provided 5 g/d of both cis-9, trans-11 CLA and trans-10, cis-12 CLA.617
All values are LSM618
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